FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2953375881> ?p ?o ?g. }

• W2953375881 endingPage "217" @default.
• W2953375881 startingPage "211" @default.
• W2953375881 abstract "This exploratory single-arm phase II study evaluated the efficacy and safety of RRx-001 followed by reintroduction of platinum plus etoposide in patients with previously treated small-cell lung cancer (SCLC). Patients were treated with RRx-001 4 mg IV on day 1 of each week of a 21-day cycle followed at progression by re-challenge with etoposide 80–100 IV mg/m2 on days 1, 2 and 3 and cisplatin 60–80 mg/m2 IV on day 1 or carboplatin AUC 5–6 IV on day 1, every 21 days. The primary end points were overall survival (OS) and overall response rate to platinum regimen. Twenty-six patients were enroled and received at least one dose of RRx-001. The median number of prior lines of therapy was 2 (range 1–9) and 19 (73.1%) patients had platinum-resistant disease. In the intention-to-treat population, one patient (3.8%) had complete response and six (23.1%) had partial response on platinum plus etoposide. The estimated median and 12-month OS from enrolment were 8.6 months and 44.1%, respectively. The most common treatment-emergent adverse event from RRx-001 was mild discomfort at the infusion site (23%). RRx-001 followed by re-challenge with platinum plus etoposide chemotherapy is feasible and associated with promising results. NCT02489903." @default.
• W2953375881 created "2019-06-27" @default.
• W2953375881 creator A5004006370 @default.
• W2953375881 creator A5010960061 @default.
• W2953375881 creator A5011500408 @default.
• W2953375881 creator A5022267430 @default.
• W2953375881 creator A5031420337 @default.
• W2953375881 creator A5033414821 @default.
• W2953375881 creator A5037223246 @default.
• W2953375881 creator A5040289016 @default.
• W2953375881 creator A5044613951 @default.
• W2953375881 creator A5054133895 @default.
• W2953375881 creator A5058710250 @default.
• W2953375881 creator A5080011474 @default.
• W2953375881 creator A5091065198 @default.
• W2953375881 date "2019-06-24" @default.
• W2953375881 modified "2023-10-08" @default.
• W2953375881 title "RRx-001 followed by platinum plus etoposide in patients with previously treated small-cell lung cancer" @default.
• W2953375881 cites W1147349766 @default.
• W2953375881 cites W1601800607 @default.
• W2953375881 cites W1857296891 @default.
• W2953375881 cites W1971264126 @default.
• W2953375881 cites W1990676527 @default.
• W2953375881 cites W2014694740 @default.
• W2953375881 cites W2019607817 @default.
• W2953375881 cites W2035891246 @default.
• W2953375881 cites W2059799711 @default.
• W2953375881 cites W2066847273 @default.
• W2953375881 cites W2074999094 @default.
• W2953375881 cites W2084773521 @default.
• W2953375881 cites W2100158834 @default.
• W2953375881 cites W2101571970 @default.
• W2953375881 cites W2103802402 @default.
• W2953375881 cites W2117569715 @default.
• W2953375881 cites W2126022863 @default.
• W2953375881 cites W2131664752 @default.
• W2953375881 cites W2134307788 @default.
• W2953375881 cites W2141476381 @default.
• W2953375881 cites W2152114243 @default.
• W2953375881 cites W2169999184 @default.
• W2953375881 cites W2291578715 @default.
• W2953375881 cites W2343868954 @default.
• W2953375881 cites W2418354692 @default.
• W2953375881 cites W2561423762 @default.
• W2953375881 cites W2573907113 @default.
• W2953375881 cites W2620975046 @default.
• W2953375881 cites W2729256052 @default.
• W2953375881 cites W2893960509 @default.
• W2953375881 doi "https://doi.org/10.1038/s41416-019-0504-8" @default.
• W2953375881 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6738071" @default.
• W2953375881 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31231122" @default.
• W2953375881 hasPublicationYear "2019" @default.
• W2953375881 type Work @default.
• W2953375881 sameAs 2953375881 @default.
• W2953375881 citedByCount "28" @default.
• W2953375881 countsByYear W29533758812019 @default.
• W2953375881 countsByYear W29533758812020 @default.
• W2953375881 countsByYear W29533758812021 @default.
• W2953375881 countsByYear W29533758812022 @default.
• W2953375881 countsByYear W29533758812023 @default.
• W2953375881 crossrefType "journal-article" @default.
• W2953375881 hasAuthorship W2953375881A5004006370 @default.
• W2953375881 hasAuthorship W2953375881A5010960061 @default.
• W2953375881 hasAuthorship W2953375881A5011500408 @default.
• W2953375881 hasAuthorship W2953375881A5022267430 @default.
• W2953375881 hasAuthorship W2953375881A5031420337 @default.
• W2953375881 hasAuthorship W2953375881A5033414821 @default.
• W2953375881 hasAuthorship W2953375881A5037223246 @default.
• W2953375881 hasAuthorship W2953375881A5040289016 @default.
• W2953375881 hasAuthorship W2953375881A5044613951 @default.
• W2953375881 hasAuthorship W2953375881A5054133895 @default.
• W2953375881 hasAuthorship W2953375881A5058710250 @default.
• W2953375881 hasAuthorship W2953375881A5080011474 @default.
• W2953375881 hasAuthorship W2953375881A5091065198 @default.
• W2953375881 hasBestOaLocation W29533758811 @default.
• W2953375881 hasConcept C126322002 @default.
• W2953375881 hasConcept C141071460 @default.
• W2953375881 hasConcept C143998085 @default.
• W2953375881 hasConcept C197934379 @default.
• W2953375881 hasConcept C2776256026 @default.
• W2953375881 hasConcept C2776694085 @default.
• W2953375881 hasConcept C2778119113 @default.
• W2953375881 hasConcept C2778239845 @default.
• W2953375881 hasConcept C2781413609 @default.
• W2953375881 hasConcept C2781451048 @default.
• W2953375881 hasConcept C2908647359 @default.
• W2953375881 hasConcept C71924100 @default.
• W2953375881 hasConcept C90924648 @default.
• W2953375881 hasConcept C99454951 @default.
• W2953375881 hasConceptScore W2953375881C126322002 @default.
• W2953375881 hasConceptScore W2953375881C141071460 @default.
• W2953375881 hasConceptScore W2953375881C143998085 @default.
• W2953375881 hasConceptScore W2953375881C197934379 @default.
• W2953375881 hasConceptScore W2953375881C2776256026 @default.
• W2953375881 hasConceptScore W2953375881C2776694085 @default.
• W2953375881 hasConceptScore W2953375881C2778119113 @default.
• W2953375881 hasConceptScore W2953375881C2778239845 @default.
• W2953375881 hasConceptScore W2953375881C2781413609 @default.

• next